Archives: Speakers

Dr. Erin (Meyer) Goodhue, DO, MPH, is Director of Transfusion and Apheresis Services at The Ohio State University Wexner Medical Center. She brings 20+ years of leadership across academic medicine, pediatric care, industry, and global research. Prior to her current role, Dr. Goodhue served as Director of Global Clinical Research at Terumo BCT and held clinical leadership roles at Nationwide Children’s Hospital and the American Red Cross. She earned her DO from the University of New England, an MPH from Dartmouth, and completed faculty appointments at Harvard, Emory, and Dartmouth.

Dr. Kate Rochlin has served as IN8bio’s Chief Operating Officer since December 2021 and previously as their VP, Operations and Innovation. She has 19+ years of expertise in strategic company development & operations, IP, CMC, and Clinical manufacturing of advanced therapies. She was previously the Chief Business Officer at Curadigm, a Cambridge-based spin-out of Nanobiotix focused on RNA therapeutic bioavailability. Prior, Dr. Rochlin co-founded and served as CSO at Immunovent in New York City. Dr. Rochlin earned a Ph.D. in Molecular Biology and Genetics from Weill Cornell Medical College, researched at Sloan Kettering Institute, and a BA from the University of Pennsylvania.

Dr. Ortega holds a doctorate in Molecular Biology and Analytical Chemistry from the University of Hawaii at Manoa. With a strong background in mass spectrometry, she serves as the Associate Director of Analytical Services at TriLink Biotechnologies. As part of the Analytical Development team, Dr. Ortega specializes in the physicochemical analysis of mRNA, oligonucleotides (i.e. gRNA), and small molecules such as NTPs and CleanCap® analogs. Her commitment to analytical excellence, combined with her scientific expertise, drives the development of robust methodologies to effectively fulfill client analytical requests and expand TriLink’s portfolio of analytical testing services.

Dr. Cody Palumbo is a Senior Application Scientist in Technical Design at TriLink BioTechnologies, where he partners with customers to support gRNA, oligonucleotide, and gene editing workflows by providing technical guidance and customized solutions. He brings deep expertise in CRISPR-based technologies and therapeutic development, drawing on years of experience across biotech and pharmaceutical settings. Prior to TriLink, Dr. Palumbo served as Associate Director of Gene Editing Process Development and Tech Transfer at Sana Biotechnology and led a team of Process Development scientists at Bristol Myers Squibb focused on gene editing tools for cell therapies. He holds a Ph.D. in Chemistry from the University of California, Davis. Dr. Palumbo is passionate about bridging technical innovation with real-world impact and frequently speaks on the evolving landscape of genome editing technologies.

Beatriz Valle trabaja en el equipo de Tecnología y Servicios Empresariales (ETS) de GlobalData. Su función consiste en el análisis competitivo de las tendencias tecnológicas en torno a los centros de datos y las tecnologías de inteligencia artificial, con especial atención a la IA generativa, sus productos y servicios. Valle ha sido analista del sector desde 2006, trabajando para varias empresas globales y cuenta con experiencia en consultoría. Ha sido citada en numerosas publicaciones financieras y comerciales, como Reuters, Forbes, Computing, The Register, DataCenterDynamics, DataCenter Knowledge, Network World, Futurism, Tech Monitor, Wired, etc.

NIKEN PRAWESTI has embarked on her journey in the hospitality industry 15 years ago. Skilled in negotiation, business planning, and leadership, she founded and led Liberta Hotel International (LHI), a hotel management company focused on lifestyle hospitality since 2020. Her expertise lies in leveraging data-driven insights to craft targeted and innovative business solutions. Since its establishment, LHI has managed hotels and F&B establishments around Indonesia, transforming hospitality industry into a more dynamic and technology-driven one. Niken has also been an active contributor to the World Bank since 2017, specializing in Women, Business, and the Law Practice group. In her free time, she enjoys reading and golf.

A fermentation expert, author & founder of L.A Brewery.  Louise worked in the creative industry for 10 years before discovering her love for fermentation.  She started her first kombucha business in her kitchen in 2013, published her first drinks fermentation book in 2016 and launched L.A Brewery in 2017.  Louise is currently the Creative Director for L.A Brewery, writing her second book and teaches fermentation classes in her spare time.

Emma Thackray is the co-founder of Hip Pop, one of the UK’s fastest-growing challenger soft drink brands. She launched the business in 2019 with a clear goal: to make better-for-you drinks that taste great, without sweeteners or artificial ingredients. Hip Pop uses real fruit, live cultures and functional ingredients to deliver bold flavour with real benefits.

Before founding Hip Pop, Emma led Dolly Parton’s Imagination Library in the UK, she now brings that same purpose-driven approach to disrupting the soft drinks space.

Hip Pop’s award-winning sodas and kombuchas are stocked in major retailers including Sainsbury’s, Morrisons M&S, and Co-op. Under Emma’s leadership, the brand has won multiple Great Taste Awards and been recognised for its rapid growth and innovation.

For Emma, it is not just about what goes into your drink. It is about choosing better, feeling better and enjoying every sip.

Todd holds an MBA from the University of Manitoba. His career in brand and innovation has included living in Toronto, Geneva, Singapore and Hong Kong working with research giants Nielsen and YouGov and more recently C&C Group on the producer side. Todd joined the Ai Palette- Globaldata team in early 2025

His client work has included engagements with Starbucks, Heineken, Pernod Ricard, Dannon, Lidl, Ferrero, Disney, HSBC and The British Olympic Association